IN182555B - - Google Patents

Info

Publication number
IN182555B
IN182555B IN347MA1996A IN182555B IN 182555 B IN182555 B IN 182555B IN 347MA1996 A IN347MA1996 A IN 347MA1996A IN 182555 B IN182555 B IN 182555B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Bobby W Sandage Jr
Marc Fisher
Kenneth W Locke
Original Assignee
Interneuron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23578854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN182555(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Interneuron Pharma filed Critical Interneuron Pharma
Publication of IN182555B publication Critical patent/IN182555B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN347MA1996 1995-03-06 1996-03-06 IN182555B (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39926295A 1995-03-06 1995-03-06

Publications (1)

Publication Number Publication Date
IN182555B true IN182555B (enEXAMPLES) 1999-05-01

Family

ID=23578854

Family Applications (1)

Application Number Title Priority Date Filing Date
IN347MA1996 IN182555B (enEXAMPLES) 1995-03-06 1996-03-06

Country Status (5)

Country Link
US (2) US5872108A (enEXAMPLES)
KR (1) KR19980702724A (enEXAMPLES)
IL (1) IL147477A (enEXAMPLES)
IN (1) IN182555B (enEXAMPLES)
ZA (1) ZA961791B (enEXAMPLES)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6732369B1 (en) * 1995-10-02 2004-05-04 Starsight Telecast, Inc. Systems and methods for contextually linking television program information
US6057301A (en) * 1997-12-24 2000-05-02 Interneuron Pharmaceuticals, Inc. Hyperhydrated citicoline, process and use
US6379882B1 (en) * 1998-09-14 2002-04-30 Elan Pharmaceuticals, Inc. Method for selecting compounds for treating ischemia-related cellular damage
ES2169986B1 (es) 2000-03-14 2003-06-16 Ferrer Int Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.
CA2429196A1 (en) * 2000-03-24 2001-10-04 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
US7235649B2 (en) * 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
US7034054B2 (en) * 2000-12-15 2006-04-25 Galileo Pharmaceuticals, Inc. Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
US20040045560A1 (en) * 2002-05-23 2004-03-11 New England Medical Center Hospitals, Inc. Computer-assisted multi-dimensional patient-selection
AU2005244816B2 (en) * 2004-05-13 2011-09-29 Massachusetts Institute Of Technology Uridine effects on dopamine release
ES2532912T3 (es) 2005-06-01 2015-04-01 Edison Pharmaceuticals, Inc. Compuestos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras condiciones y modulación de biomarcadores energéticos
EA019675B1 (ru) 2006-02-22 2014-05-30 Эдисон Фармасьютикалз, Инк. Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q
SI2470168T1 (en) 2009-08-26 2018-05-31 Bioelectron Technology Corporation Procedures for the prevention and treatment of brain ischemia
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
WO2012164563A1 (en) 2011-06-01 2012-12-06 Brain Watch Ltd. Isotopically labeled cdp-choline and uses thereof
NZ702242A (en) 2012-05-31 2016-03-31 Asahi Kasei Pharma Corp Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
JP6905527B2 (ja) 2015-12-17 2021-07-21 ピーティーシー セラピューティクス， インコーポレイテッド 酸化ストレス障害を処置するためのフルオロアルキル、フルオロアルコキシ、フェノキシ、ヘテロアリールオキシ、アルコキシ、およびアミノ１，４−ベンゾキノン誘導体
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517769B2 (enEXAMPLES) * 1972-01-10 1980-05-14
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
IT1207106B (it) * 1980-04-18 1989-05-17 Made Italiana Srl Ora Searle I Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale
JPS6043078B2 (ja) * 1980-10-31 1985-09-26 株式会社興人 シチジンジリン酸コリンの製法
JPS6043079B2 (ja) * 1980-12-25 1985-09-26 株式会社興人 シチジン二リン酸コリンの製造方法
JPS57108099A (en) * 1980-12-25 1982-07-05 Kohjin Co Ltd Preparation of choline cytidine diphosphate

Also Published As

Publication number Publication date
IL147477A (en) 2010-02-17
KR19980702724A (ko) 1998-08-05
ZA961791B (en) 1996-09-10
US5801160A (en) 1998-09-01
US5872108A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
IN186066B (enEXAMPLES)
IN186075B (enEXAMPLES)
IN182555B (enEXAMPLES)
FR2729757B1 (enEXAMPLES)
ECSDI950283S (enEXAMPLES)
IN187590B (enEXAMPLES)
IN185479B (enEXAMPLES)
IN177927B (enEXAMPLES)
IN183534B (enEXAMPLES)
CN3034591S (enEXAMPLES)
CN3033225S (enEXAMPLES)
CN3036648S (enEXAMPLES)
CN3036647S (enEXAMPLES)
CN3036463S (enEXAMPLES)
CN3035871S (enEXAMPLES)
CN3035870S (enEXAMPLES)
CN3035868S (enEXAMPLES)
CN3035323S (enEXAMPLES)
CN3030542S (enEXAMPLES)
CN3035300S (enEXAMPLES)
CN3030489S (enEXAMPLES)
CN3034896S (enEXAMPLES)
CN3034829S (enEXAMPLES)
EP0721994A3 (enEXAMPLES)
CN3037189S (enEXAMPLES)